With the human pathologic tissue specimens from patients (classified by TNM staging) and human tissue arrays by IHC with specific antibody against ANO1, the expression of ANO1 was found to be closely correlated with the malignancy of the prostate cancers. Here, ANO1 is linked to prostate carcinoma.